As the healthcare sector expands drastically, there are notable developments witnessed in various medical procedures and therapies, including the ones used for the treatment for gastrointestinal diseases. The increasing prevalence of diseases such as gastroparesis act as a catalyst of growth for the overall gastric pacemakers market. Gastric pacemakers can be programmed to improve the frequency of gastric contractions, making it a revolutionary approach to treating such diseases. An exceptional research study presented by Future Market Insights (FMI) states more such significant factors that are responsible for the effective growth of the gastric pacemakers market.
According to the FMI study, there are various activities and noteworthy developments made in the gastric pacemakers market that are expected to bring promising growth opportunities to the market players. The increasing incidents of gastroparesis are further contributing to increasing the implementation of gastric pacemakers. For instance, the Allegheny Health Network’s Forbes Hospital, while treating a woman suffering from gastroparesis, implanted a gastric pacemaker which was the first gastric pacemaker implantation of the Hospital. This innovative technology enables patients to live a more comfortable life.
In light of the increasing emphasis gained by gastric pacemakers, the requirements for gastric electric stimulators are expected to rise significantly.
Increasing Gastric-related Conditions Fueling Demand for Gastric Electric Stimulators
The global gastric electric stimulators market is expected to grow at a high growth rate of about 6.4 percent over the forecast period. The increasing demand for gastric electric stimulators is stimulated by various factors such as the surging gastroparesis incidents, the increased funding providing by government bodies, and the shifting preference towards minimally invasive procedures. The FMI study opines that the sales of gastric electric stimulators are likely to witness a major proliferation in the future owing to the encouraging reimbursement schemes.
FMI study further unveils that there are several investments made in the research and development activities and a substantial rise in the number of clinical trials, which could act as a growth catalyst for the market for gastric electric stimulators. Moreover, the adoption of gastric electric stimulators in place of gastrectomy in patients suffering from severe gastric dysfunction is expected to gain momentum over time. These aforementioned factors are expected to accelerate the demand for gastric electric stimulators through the period of forecast.
The gastric electric stimulators market is a highly consolidated market with few players dominating the entire market. Some of the key players serving the gastric electric stimulators market include IntraPace Inc., ReShape Lifesciences, Inc., Medtronic Plc., Changzhou Ruishen Medical Equipment Co., Ltd, and others. Superior product offerings along with a regional expansion are some of the key strategies adopted by the prominent gastric electric stimulators for gaining a considerable market presence. For instance, E-Motion Medical introduced an acute digestive dysmotility stimulator for which the company received a CE Mark Approval in the European Union. This stimulation therapy system is designed to treat acute gastrointestinal dysmotility.
Download Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8992